Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R > Treatment > Co: USA. C. Brand Lenalidomide Cap>

---

Co: USA. C. Brand Lenalidomide Cap>'s subsections
(*) EU Approval Date: 2016. 07.15.
(*) USA Approval Date: 2013. 06.05
>R>Treat>2 Prior Medicines>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 19
Patent>UpDate: 2018. 10.30.
Patent>USA Expiration: 2019. 12.31.
TradeMark
TradeMark Web-Site

Co: USA. C. Brand Lenalidomide Cap>'s products
This section has no products